Triple-negative breast cancer (TNBC) is defined by a lack of expression of the hormone receptors estrogen receptor α (ER) and progesterone receptor (PR) and of the human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.